Pharmaceutical Excipients for Oral Formulations

Pharmaceutical Excipients for Oral Formulations Market Outlook

The global pharmaceutical excipients market for oral formulations is projected to reach approximately $5.5 billion by 2033, growing at a CAGR of around 6.1% during the forecast period from 2025 to 2033. This growth is largely attributed to the rising demand for efficient drug delivery systems which ensure enhanced bioavailability and patient compliance. The increasing prevalence of chronic diseases, combined with the growing geriatric population, has notably driven the demand for oral medications, thereby boosting the excipients market. Furthermore, advancements in pharmaceutical technology and the continuous innovation in formulation science are expected to propel market growth. Pharmaceutical companies are increasingly investing in research and development to create innovative excipients that improve drug stability and effectiveness, further contributing to market expansion.

Growth Factor of the Market

Several factors are driving the growth of the pharmaceutical excipients market for oral formulations. One of the primary drivers is the rapid evolution of the pharmaceutical industry toward more patient-friendly drug formulations, which has heightened the demand for excipients that enhance drug release and absorption. Additionally, the ongoing trend towards personalized medicine is compelling manufacturers to develop customized excipients that cater to specific patient needs, thereby broadening their market reach. Moreover, regulatory support for the use of advanced excipients in drug formulations has further accelerated market growth. The increasing focus on generic drugs due to cost-effectiveness is also boosting the market, as generics rely heavily on excipients for formulation stability and performance. Furthermore, the advent of newer technologies in drug formulation, such as nanotechnology and 3D printing, is creating an opportunity for innovative excipients in the pharmaceutical landscape.

Key Highlights of the Market

• The global pharmaceutical excipients market is expected to reach $5.5 billion by 2033.
• Projected CAGR for the market is around 6.1% from 2025 to 2033.
• Oral formulations significantly dominate market share due to rising patient compliance.
• Technological advancements are driving innovation in excipient formulations.
• Increased focus on personalized medicine is influencing the development of specialized excipients.

By Product Type

Binders:

Binders are crucial excipients in pharmaceutical formulations, particularly in oral solid dosage forms like tablets. They ensure the cohesion of the powdered ingredients during the production process and maintain the structural integrity of the final product. Binders improve the flow properties of the powder blend and enhance the compressibility of the mixture, which is vital for tablet formation. Common binder materials include cellulose derivatives, polyvinylpyrrolidone (PVP), and various natural gums. The demand for binders is driven by the increasing production of tablets and capsules, as well as the rising need for modified-release formulations, which require specialized binders to control the release profile of active pharmaceutical ingredients (APIs). As the market moves towards more complex and customized formulations, the role of binders becomes increasingly significant.

Fillers:

Fillers, also known as diluents, are used to increase the bulk of the formulation, making it easier to handle and process. They play a vital role in ensuring the dosage accuracy of the pharmaceutical product. Common filler materials include lactose, microcrystalline cellulose, and starch. The increasing prevalence of chronic diseases and the subsequent rise in drug consumption are propelling the demand for fillers in the market. Additionally, the growth of generic drugs, which often require fillers to meet the required dosage form, is significantly contributing to the expansion of this segment. The development of novel fillers that enhance the bioavailability of drugs is also gaining traction, leading to a shift towards more innovative excipients in the market.

Disintegrants:

Disintegrants are essential for facilitating the breakup of tablets in the gastrointestinal tract, ensuring that the active ingredients are released effectively for absorption. Common disintegrants include starch, croscarmellose sodium, and sodium starch glycolate. The demand for disintegrants is increasing due to the growing preference for fast-dissolving tablets and formulations aimed at enhancing patient compliance. Innovations in disintegrant technology, including super disintegrants that work more efficiently at lower concentrations, are allowing for improved bioavailability and performance of oral medications. As the trend towards patient-centric formulations continues, the importance of disintegrants within the pharmaceutical excipients market cannot be overstated.

Coatings:

Coatings are employed in oral formulations primarily to mask flavors, enhance stability, and control the release profile of active ingredients. They serve a dual purpose of providing aesthetic appeal while also protecting the drug from environmental factors. Popular coating materials include hydroxypropyl methylcellulose (HPMC) and various polymer-based coatings. The increasing trend toward developing enteric-coated and sustained-release formulations is driving the demand for innovative coating excipients. The market is witnessing significant advancements in coating technologies, leading to enhanced performance characteristics and patient compliance with oral medications. As pharmaceutical companies continue to prioritize product stability and appearance, the coatings segment of the market is expected to expand significantly.

Lubricants:

Lubricants play a critical role in the manufacturing of tablets by ensuring smooth processing during compression and ejection from molds. They help to reduce friction between the tablet and the machinery, which enhances the overall efficiency of the production process. Commonly used lubricants include magnesium stearate and stearic acid. The need for lubricants is steadily increasing due to the growing demand for high-speed tablet manufacturing and the production of complex formulations that require specific lubricating properties. The development of new lubricants that provide additional benefits, such as improved flowability and reduced dusting, is further stimulating growth in this segment. The lubricant segment is becoming increasingly important as manufacturers seek to optimize production while maintaining product quality.

By Application

Oral Formulations:

Oral formulations are the most significant application segment within the pharmaceutical excipients market. This segment encompasses a wide range of dosage forms, including tablets, capsules, and liquids. The high demand for oral medications is driven by the convenience of administration and patient preference. As the population ages and chronic diseases become more prevalent, the need for effective and accessible oral medications continues to grow. The development of innovative excipients that enhance drug solubility, stability, and bioavailability is crucial for improving the efficacy of oral formulations. This segment is expected to witness substantial growth over the forecast period as pharmaceutical companies increasingly focus on developing novel oral drug delivery systems that improve patient adherence.

Topical Formulations:

Topical formulations, including creams, ointments, and gels, are another vital application area for pharmaceutical excipients. The growing focus on dermatological and cosmetic products has significantly contributed to the expansion of this segment. Excipients used in topical formulations serve various functions, such as emulsifiers, stabilizers, and thickening agents, ensuring the efficacy and pleasant application of products. The rise in skincare awareness and the increasing prevalence of skin disorders are propelling the demand for topical formulations. Innovations in the development of excipients that enhance skin penetration and drug release profiles are driving advancements in this application segment, highlighting the importance of excipients in the overall effectiveness of topical therapies.

Parenteral Formulations:

Parenteral formulations are critical for delivering medications directly into the body, bypassing the gastrointestinal tract. This application segment includes injectables and infusions that require high-quality excipients to ensure product stability and safety. The growth of parenteral formulations is driven by the increasing prevalence of chronic diseases that necessitate precise and controlled drug delivery. Excipients used in parenteral formulations play essential roles in solubilizing active ingredients, stabilizing the formulation, and maintaining sterility. As the market shifts towards biologics and biosimilars, the demand for specialized excipients that can accommodate the unique requirements of these products is also rising. The parenteral segment is expected to witness continuous growth as the healthcare industry emphasizes patient safety and efficacy in drug delivery.

Others:

This category includes various other formulations that do not fall under the standard oral, topical, or parenteral categories. Excipients used in these applications may serve multiple purposes, including enhancing stability, improving product formulation, or delivering active ingredients in innovative ways. The growing interest in alternative dosage forms such as transdermal patches and nasal sprays is driving innovation in this segment. As pharmaceutical companies explore new and diverse routes of administration, the demand for versatile excipients that can adapt to different formulation needs will continue to grow, providing opportunities for market expansion in the "Others" application segment.

By Distribution Channel

Pharmaceutical Companies:

Pharmaceutical companies are major distributors of excipients, utilizing them in the formulation of their drug products. This channel provides a direct link between excipient manufacturers and businesses developing pharmaceutical products, ensuring that the right excipients are matched to specific formulation needs. The growth of this distribution channel is influenced by the continuous demand for new excipients that enhance drug performance and meet regulatory standards. Additionally, the increasing focus on innovation within pharmaceutical companies is driving the demand for specialized excipients, thus expanding the market's reach through this channel.

Distributors:

Distributors play a vital role in the pharmaceutical excipients market by connecting manufacturers with end-users across various sectors. They provide a broad range of excipients from multiple suppliers, allowing for greater flexibility in choosing the right materials for specific applications. The growth of this distribution channel is supported by the increasing complexity of pharmaceutical formulations, which necessitate a diverse range of excipients. Distributors also contribute to the market by offering value-added services, such as technical support and warehousing, which aid pharmaceutical companies in optimizing their production processes. The demand for reliable distributors is expected to rise as manufacturers look for efficient supply chain solutions.

Online Pharmacies:

The rise of e-commerce has led to the emergence of online pharmacies as a significant distribution channel for pharmaceutical excipients. This channel provides easy access to a wide range of excipients, allowing formulators to procure materials conveniently and quickly. The growing trend towards online purchasing is driven by the increasing digitization of the pharmaceutical industry and the need for efficient procurement processes. Online pharmacies often provide competitive pricing and a broader selection of excipients compared to traditional brick-and-mortar stores. As more pharmaceutical companies embrace digital solutions, the importance of online pharmacies in the excipients market is likely to continue growing, creating new opportunities for suppliers.

Others:

This category encompasses various alternative distribution channels that do not fit neatly into the primary segments. It includes specialized distributors, wholesalers, and direct-to-consumer sales platforms that focus on niche markets within the pharmaceutical industry. The growth of alternative distribution channels is driven by the increasing need for tailored excipient solutions and the desire for quick access to materials. These channels often cater to small and medium-sized enterprises (SMEs) that require specific excipients for unique formulations. The diversification of distribution channels in the pharmaceutical excipients market is expected to enhance overall accessibility and foster innovation.

By Ingredient Type

Polyols:

Polyols, such as sorbitol and mannitol, are widely used in pharmaceutical formulations due to their excellent functional properties, including sweetness, moisture retention, and stability. They are particularly popular in oral formulations, as they can enhance the taste of medications while also serving as excipients that improve the flowability of powders. The increasing demand for sugar-free formulations, driven by growing health awareness, is boosting the use of polyols in the market. Additionally, polyols play a crucial role in sustaining moisture levels in formulations, which is vital for maintaining product quality over time. As the trend towards healthier formulations continues, polyols are likely to gain greater prominence in the pharmaceutical excipients market.

Cellulose:

Cellulose derivatives are among the most widely used excipients in the pharmaceutical industry. They are valued for their versatility in various applications, including binders, fillers, and disintegrants. Cellulose is derived from plants, making it a natural choice for formulations seeking to minimize synthetic ingredients. The demand for cellulose derivatives is driven by their ability to enhance the stability and efficacy of pharmaceutical products. Innovations in cellulose-based excipients, such as modified cellulose, are creating new opportunities for enhanced formulation performance. The increasing consumer preference for natural and clean-label products is also contributing to the growth of cellulose in the excipients market.

Starch:

Starch is a versatile excipient commonly used in pharmaceutical formulations for its binding, disintegrating, and thickening properties. It is an essential ingredient in tablet and capsule formulations due to its ability to enhance flowability and compressibility. The rising demand for starch-based excipients is driven by the growing production of oral solid dosage forms, which are favored for their convenience and efficacy. Additionally, the continued exploration of natural alternatives in formulations is further propelling the use of starch, as it is derived from renewable resources. Innovations in modified starches designed to improve drug release profiles are also contributing to the segment's growth in the pharmaceutical excipients market.

Polymers:

Polymers are integral to the pharmaceutical excipients market, particularly in the development of controlled-release formulations. Polymers such as polyethylene glycol (PEG) and polyvinyl alcohol (PVA) are widely utilized as excipients due to their ability to modify the release rate of active ingredients. The demand for polymer-based excipients is fueled by the growing focus on prolonged-release formulations that improve patient adherence and therapeutic outcomes. The versatility of polymers allows for customization in various formulations, catering to specific release profiles and enhancing the overall effectiveness of medications. As research on polymer chemistry continues, the market is expected to see advancements in polymer-based excipients that offer enhanced performance characteristics.

Others:

This category includes a range of alternative ingredients used in pharmaceutical formulations that do not fall under the primary ingredient types. These may include natural gums, waxes, and other niche materials that serve specific excipient functions in various formulations. The demand for these alternative ingredients is growing as pharmaceutical companies explore innovative solutions to enhance product stability and performance. The trend towards sustainable sourcing and natural ingredients is also influencing the growth of this segment, as formulators seek to incorporate more environmentally friendly options into their products. The "Others" category is expected to expand as research continues to identify and develop new excipient materials for diverse pharmaceutical applications.

By Region

North America leads the pharmaceutical excipients market, accounting for roughly 35% of the global market share. The region's significant market size can be attributed to the well-established pharmaceutical industry and continuous advancements in drug formulation technologies. The prevalence of chronic diseases and a growing focus on pharmaceutical R&D further fuel the demand for excipients in North America. The market in this region is projected to grow at a CAGR of 5.7% during the forecast period, driven primarily by the increasing demand for innovative drug delivery systems and the rising trend of personalized medicine. Additionally, regulatory support for the development of new excipients is expected to enhance growth opportunities within the North American market.

In Europe, the pharmaceutical excipients market is also witnessing significant growth, with an estimated market share of around 30%. The region's robust pharmaceutical manufacturing sector, coupled with a focus on research and development, plays a crucial role in driving demand for excipients. Factors such as an aging population and the rising incidence of chronic diseases are further contributing to market expansion in Europe. The market is characterized by a continuous push towards innovation in excipient formulations and the introduction of more effective drug delivery systems. As such, the European market is expected to grow at a CAGR of approximately 5.3% over the forecast period, reflecting its importance in the global pharmaceutical excipients landscape.

Opportunities

The pharmaceutical excipients market presents numerous opportunities for growth and innovation, particularly in the context of evolving drug delivery methods and personalized medicine. The increasing demand for biologics and biosimilars has created a significant opportunity for excipient manufacturers to develop specialized materials tailored to the unique requirements of these complex formulations. This trend aligns with the broader movement towards more patient-centric therapeutic approaches, which emphasizes the importance of excipients that enhance bioavailability and improve patient adherence. Additionally, as pharmaceutical companies increasingly focus on sustainability and environmentally friendly practices, there is an opportunity for excipient manufacturers to innovate and supply green alternatives that meet regulatory standards while also appealing to health-conscious consumers.

Another major opportunity lies in the ongoing advancements in formulation technologies, such as 3D printing and nanotechnology, which are reshaping the landscape of pharmaceutical manufacturing. These technologies require specialized excipients that can cater to their unique characteristics and performance needs. As more pharmaceutical companies adopt these cutting-edge technologies, the demand for innovative excipients is expected to increase significantly. Furthermore, the rise of e-commerce and online pharmacies is creating new distribution channels for excipient suppliers, expanding their reach and enhancing accessibility for formulators. The combination of these opportunities positions the pharmaceutical excipients market for sustained growth and transformation in the coming years.

Threats

Despite the promising growth prospects, the pharmaceutical excipients market faces several threats that could impact its expansion. One of the primary concerns is the stringent regulatory environment governing the pharmaceutical industry. Compliance with evolving regulations can pose significant challenges for excipient manufacturers, particularly smaller companies with limited resources. The constant need for product registration and safety assessments can result in increased operational costs and delayed time-to-market for new excipients. Additionally, the potential for regulatory changes could disrupt established supply chains and impact the availability of certain excipients, leading to production challenges for pharmaceutical companies.

Another significant threat to the market is the intensification of competition among excipient manufacturers. As the demand for excipients grows, numerous players are entering the market, which can lead to price erosion and reduced profit margins. The increasing focus on research and development may also drive up costs for manufacturers, pushing them to seek economies of scale to remain competitive. Furthermore, the rapid pace of technological advancements means that companies must continually innovate to keep up with market demands, which can be resource-intensive. The combination of these challenges necessitates strategic planning and adaptability from excipient manufacturers to navigate the competitive landscape effectively.

Competitor Outlook

• Roquette Frères
• Dow Chemical Company
• Evonik Industries AG
• FMC Corporation
• Grain Processing Corporation
• Hawkins, Inc.
• Merck KGaA
• Colorcon, Inc.
• SPI Pharma
• Asahi Kasei Corporation
• JRS Pharma
• Wacker Chemie AG
• Celanese Corporation
• Innophos Holdings, Inc.
• Qualicaps, Inc.

The overall competitive landscape of the pharmaceutical excipients market is characterized by a mix of established players and emerging companies that are continually innovating to meet the evolving needs of the pharmaceutical industry. Major companies such as Roquette Frères and Dow Chemical Company are at the forefront, leveraging their extensive expertise and resources to develop cutting-edge excipients that enhance drug formulations. These companies are heavily investing in research and development to create novel excipients that can cater to specific pharmaceutical applications, thereby strengthening their market position. Additionally, partnerships and collaborations among major players and smaller firms are common, facilitating the exchange of knowledge and technology for enhanced product offerings.

Moreover, the competitive landscape is witnessing an increasing trend toward sustainability, with companies like Evonik Industries AG and Merck KGaA focusing on eco-friendly excipient solutions that align with consumer preferences for natural ingredients. These initiatives not only foster brand loyalty but also meet the growing demand for environmentally conscious products within the pharmaceutical sector. Companies are also adopting strategic mergers and acquisitions to expand their portfolios and enhance their market reach, enabling them to respond more effectively to changing consumer demands and industry trends.

In summary, the pharmaceutical excipients market is dynamic and continually evolving, driven by technological advancements and changing consumer preferences. As major players like FMC Corporation and Colorcon, Inc. continue to innovate and expand their product offerings, the market is poised for significant growth over the coming years. The combined efforts of established firms and emerging players will be crucial in addressing the challenges and opportunities that lie ahead in this vibrant industry. As competition intensifies, the focus on quality, innovation, and customer satisfaction will remain a key differentiator for companies seeking to succeed in the pharmaceutical excipients market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 JRS Pharma
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 SPI Pharma
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Hawkins, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Colorcon, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 FMC Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Qualicaps, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Wacker Chemie AG
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Celanese Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Dow Chemical Company
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Evonik Industries AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Roquette Frères
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Asahi Kasei Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Innophos Holdings, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Grain Processing Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Pharmaceutical Excipients for Oral Formulations Market, By Application
    • 6.1.1 Oral Formulations
    • 6.1.2 Topical Formulations
    • 6.1.3 Parenteral Formulations
    • 6.1.4 Others
  • 6.2 Pharmaceutical Excipients for Oral Formulations Market, By Product Type
    • 6.2.1 Binders
    • 6.2.2 Fillers
    • 6.2.3 Disintegrants
    • 6.2.4 Coatings
    • 6.2.5 Lubricants
  • 6.3 Pharmaceutical Excipients for Oral Formulations Market, By Ingredient Type
    • 6.3.1 Polyols
    • 6.3.2 Cellulose
    • 6.3.3 Starch
    • 6.3.4 Polymers
    • 6.3.5 Others
  • 6.4 Pharmaceutical Excipients for Oral Formulations Market, By Distribution Channel
    • 6.4.1 Pharmaceutical Companies
    • 6.4.2 Distributors
    • 6.4.3 Online Pharmacies
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Pharmaceutical Excipients for Oral Formulations Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Pharmaceutical Excipients for Oral Formulations market is categorized based on

By Product Type

• Binders
• Fillers
• Disintegrants
• Coatings
• Lubricants

By Application

• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Others

By Distribution Channel

• Pharmaceutical Companies
• Distributors
• Online Pharmacies
• Others

By Ingredient Type

• Polyols
• Cellulose
• Starch
• Polymers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Roquette Frères
• Dow Chemical Company
• Evonik Industries AG
• FMC Corporation
• Grain Processing Corporation
• Hawkins, Inc.
• Merck KGaA
• Colorcon, Inc.
• SPI Pharma
• Asahi Kasei Corporation
• JRS Pharma
• Wacker Chemie AG
• Celanese Corporation
• Innophos Holdings, Inc.
• Qualicaps, Inc.